Elsevier

Advances in Immunology

Volume 45, 1989, Pages 381-416
Advances in Immunology

The Regulators of Complement Activation (RCA) Gene Cluster

https://doi.org/10.1016/S0065-2776(08)60697-5Get rights and content

Publisher Summary

Three major interactions of the regulators of complement activation (RCA) proteins have been described: decay acceleration hastens the dissociation of the C3 convertases that produce the C3b molecules; cofactor activity irreversibly inhibits C3b and C4b effects through I-mediated proteolysis of target-bound and fluid-phase C3b and C4b; and C3b and C4b receptors are involved in the binding, transport, and clearance of foreign material in the spleen and liver, the mediation of endocytosis, and in signal transduction. The RCA proteins play major roles in the protection of cells from complement in regulation of complement activation, in processing of immune complexes, microbes, and other foreign materials, and in the activation of the immune cells. Two distinct biochemical mechanisms are instrumental in this process of biochemical interactions of the RCA proteins with C3b/C4b: decay acceleration and factor I-mediated degradation. It was not apparent that the RCA proteins were closely related when they were first being isolated and characterized. Factor H and C4bp were very different in molecular weight and each had its own ligand specificity, while the receptor, CR1, had not yet appeared structurally similar to either plasma protein. The use of pulsed-field gel electrophoresis has recently given the first detailed picture of the RCA cluster. The study of the RCA proteins has been accelerated by the availability of molecular techniques. This chapter discusses the physiological roles of the RCA family stress; the common structural and evolutionary relationships among the RCA proteins and their genes.

References (180)

  • J.P. Atkinson et al.

    Immunol. Today

    (1987)
  • L.P. Chung et al.

    Mol. Immunol.

    (1985)
  • B. Dahlback et al.

    J. Biol. Chem.

    (1984)
  • C.G. Davis et al.

    J. Biol. Chem.

    (1986)
  • P. Early et al.

    Cell

    (1980)
  • W. Gilbert

    ICN-UCLA Symp. Mol. Cell. Biol.

    (1979)
  • G. Goldberger et al.

    J. Biol. Chem.

    (1987)
  • L.A. Hebert et al.

    Kidney Int.

    (1987)
  • V.M. Holers et al.

    Immunol. Today

    (1985)
  • D.M. Kingsley et al.

    Cell (Cambridge, Mass.)

    (1986)
  • P.J. Lachmann et al.
  • N. Maeda

    J. Biol. Chem.

    (1985)
  • D.R. Abrahamson et al.

    Lab. Invest.

    (1983)
  • J. Alsenz et al.

    Biochem. J.

    (1985)
  • A. Asch et al.

    J. Exp. Med.

    (1985)
  • J.P. Atkinson et al.
  • L. Ballard et al.

    J. Immunol.

    (1987)
  • S. Barnum et al.

    Complement

    (1987)
  • J.D. Becherer et al.

    Complement

    (1987)
  • D.R. Bentley

    Biochem. J.

    (1986)
  • M. Berger et al.

    Immunology

    (1984)
  • J.F. Bohnsack et al.

    J. Immunol.

    (1986)
  • Bora, N. S., Lublin, D. M., Kumar, B. V., Hockett, R. D., Holers, V. M., and Atkinson, J. P. (1988). J. Exp. Med. (in...
  • R.D. Campbell et al.

    Philos. Trans. R. Soc. London, Ser. B.

    (1984)
  • R.D. Campbell et al.

    Annu. Rev. Immunol.

    (1988)
  • I.W. Caras et al.

    Nature (London)

    (1987)
  • M.C. Carroll et al.

    J. Exp. Med.

    (1988)
  • R.H. Carter et al.

    J. Immunol.

    (1988)
  • P.S. Changelian et al.

    J. Exp. Med.

    (1986)
  • N.V. Cheung et al.

    J. Clin. Invest.

    (1987)
  • L.P. Chung et al.

    Biosci. Rep.

    (1985)
  • L.P. Chung et al.

    Biochem. J.

    (1985)
  • D.B. Cines et al.

    J. Clin, Invest.

    (1982)
  • J. Cole et al.

    Proc. Natl. Acad. Sci. U.S.A.

    (1985)
  • N.R. Cooper et al.

    Annu. Rev. Immunol.

    (1988)
  • B. Dahlback

    Biochem. J.

    (1983)
  • B. Dahlback et al.

    Proc. Natl. Acad. Sci. U.S.A.

    (1981)
  • B. Dahlback et al.

    Proc. Natl. Acad. Sci. U.S.A.

    (1983)
  • L.S. Davis et al.

    J. Immunol.

    (1988)
  • M. Davitz et al.

    J. Exp. Med.

    (1986)
  • S.R. de Cordoba et al.

    J. Exp. Med.

    (1986)
  • S.R. de Cordoba et al.

    J. Exp. Med.

    (1985)
  • T.R. Dykman et al.

    J. Exp. Med.

    (1983)
  • T.R. Dykman et al.

    Proc. Natl. Acad. Sci. U.S.A.

    (1983)
  • T.R. Dykman et al.

    J. Exp. Med.

    (1984)
  • T.R. Dykman et al.

    J. Immunol.

    (1985)
  • A. Eden et al.

    J. Clin. Invest.

    (1973)
  • D.T. Fearon

    Proc. Natl. Acad. Sci. U.S.A.

    (1979)
  • D.T. Fearon

    J. Exp. Med.

    (1980)
  • D.T. Fearon

    J. Invest. Dermatol.

    (1985)
  • Cited by (416)

    • The Complement System

      2022, Encyclopedia of Infection and Immunity
    • Complement and SLE

      2021, Lahita’s Systemic Lupus Erythematosus
    • Complement factors-mediated modulation of autophagy

      2020, Autophagy in Immune Response: Impact on Cancer Immunotherapy
    View all citing articles on Scopus
    View full text